Clene Provides Update on ALS Clinical Development Meeting With FDA

Go back to Clene Provides Update on ALS Clinical Development Meeting With FDA
(NASDAQ: CLNN) Delayed: 3.73 -0.03 (0.8%)
Previous Close $3.76    52 Week High $ 
Open $3.73    52 Week Low $ 
Day High $3.73    P/E N/A 
Day Low $3.73    EPS $ 
Volume 289